E-LIB Suche - Ergebnisse für: Bosch, F.

1

Beyond lectures and practical courses: Teaching pharmacolog..:

Baños, J.E. ; Blanco-Reina, E. ; Bellido-Estévez, I....
Pharmacological Research. 202 (2024) - p. 107130 , 2024

Link: https://doi.org/10.1016/..

2

COMBINING CD19‐4‐1BBL (RO7227166) WITH GLOFITAMAB IS SAFE A..:

Hutchings, M. ; Dickinson, M. ; Carlo‐Stella, C....
Hematological Oncology. 41 (2023) S2 - p. 136-138 , 2023

Link: https://doi.org/10.1002/..

3

Impact of COVID‐19 infection on bispecific antibodies treat..:

Serna, A. ; Iraola‐Truchuelo, J. ; Jiménez, M....
Hematological Oncology. 41 (2023) S2 - p. 607-609 , 2023

Link: https://doi.org/10.1002/..

4

Long-term antibacterial Ag+-release biomaterials based on a..:

Molina, J. ; Valero-Gómez, A. ; Belda, J....
Colloids and Surfaces A: Physicochemical and Engineering Aspects. 676 (2023) - p. 132243 , 2023

Link: https://doi.org/10.1016/..

5

PB0488 Interaction between Rivaroxaban, Apixaban or Edoxaba..:

Olivera, P. ; Campoy Castaño, D. ; Hernandez Mata, C....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) - p. 101896 , 2023

Link: https://doi.org/10.1016/..

6

OC 46.2 Plasma Protein Signature by Targeted Mass Spectrome..:

Buijs, J. ; van Es, N. ; Anijs, R....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) - p. 100607 , 2023

Link: https://doi.org/10.1016/..

7

Identification of biomarkers for predicting central nervous..:

Pagès‐Geli, C. ; Bobillo, S. ; Abrisqueta, P....
Hematological Oncology. 41 (2023) S2 - p. 296-297 , 2023

Link: https://doi.org/10.1002/..

8

Simple and effective sol-gel methodology to obtain a bacter..:

Molina, J. ; Valero-Gómez, A. ; Pocoví-Martínez, S...
Journal of Sol-Gel Science and Technology. 108 (2023) 3 - p. 809-826 , 2023

Link: https://doi.org/10.1007/..

9

GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RE..:

Hutchings, M. ; Avigdor, A. ; Sureda, A....
Hematological Oncology. 41 (2023) S2 - p. 138-140 , 2023

Link: https://doi.org/10.1002/..

10

Phase 1 trial of EO2463 peptide‐based immunotherapy as mono..:

Pinto, A. A. ; Bosch, F. ; Bisneto, J. C. Villasboas...
Hematological Oncology. 41 (2023) S2 - p. 581-582 , 2023

Link: https://doi.org/10.1002/..

11

OC 64.4 Prediction of on Treatment Recurrent Venous Thrombo..:

Lanting, V. ; Bosch, F. ; Marshall, A....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) - p. 100600 , 2023

Link: https://doi.org/10.1016/..

12

Amélioration des signes et symptômes chez des patients atte..:

Dougados, M. ; Van Der Heijde, D. ; Baraliakos, X....
Revue du Rhumatisme. 89 (2022) - p. A132-A133 , 2022

Link: https://doi.org/10.1016/..

13

P1463: PHASE I DOSE ESCALATION OF LAVA-051, A NOVEL BISPECI..:

Broijl, A. ; van de Donk, N. ; Bosch, F....
HemaSphere. 6 (2022) - p. 1345-1346 , 2022

Link: https://doi.org/10.1097/..

14

P586: IADADEMSTAT COMBINATION WITH AZACITIDINE SHOWS ENCOUR..:

Salamero, O. ; Somervaille, T. ; Molero, A....
HemaSphere. 6 (2022) - p. 485-486 , 2022

Link: https://doi.org/10.1097/..

15

Age and metastasis – How age influences metastatic spread i..:

Pretzsch, E. ; Nieß, H. ; Bösch, F....
Cancer Epidemiology. 77 (2022) - p. 102112 , 2022

Link: https://doi.org/10.1016/..